InvestmentUpdated on 19 January 2026
ZenZen: The Future of Digital Therapeutics in Maternal Health
Co-Founder, UX Designer at ZenZen Diabetes Support
Berlin, Germany
About
ZenZen is an AI-driven health platform on a mission to break the diabetes development circle. By combining nurse-led clinical insights with proprietary AI, we are evolving from a support companion into a regulated Digital Therapeutic (DTx). We are now seeking a €600k seed investment to triple our target market by providing metabolic screening and therapy for all pregnancies.
🌟 Current Market Validation (Product-Market Fit)
We have already built a high-trust, scalable infrastructure that is currently live in 7 countries across 4 languages:
-
🥗 Adaptive AI Meal Planner: A proprietary engine that learns from user preferences and glycemic responses to provide personalized nutrition.
-
🤖 24/7 Conversational AI: An empathetic digital assistant providing real-time guidance and reducing patient anxiety.
-
📊 Low-Friction Tracking & Knowledge Hub: A clinical-grade suite (85% ORCHA score) that ensures high user retention and data accuracy.
-
Traction: 150+ active users, Fit4Start Graduate, and recipient of a €60k grant from the Luxembourg government.
🚀 The Seed Vision: Scaling to a 360° DTx Ecosystem
The €600k investment will fund our transition into a high-barrier-to-entry medical diagnostic tool, expanding our reach from high-risk management to universal pregnancy screening.
🔬 Proprietary Diagnostics & Screening We are moving diagnostics from the clinic to the home to capture the market earlier:
-
Voice-Based Biomarkers: Utilizing AI to detect metabolic distress through subtle vocal changes—a non-invasive, high-margin screening tool.
-
Home Oral Glucose Testing: Integrated at-home diagnostic kits that feed real-time data directly into our clinical dashboard.
-
Early Detection Protocols: Identifying risks weeks before traditional clinical windows.
🏥 Monetization & Ecosystem Expansion
-
Integrated Telehealth: Direct in-app specialist consultations, creating a seamless referral loop.
-
Maternal Marketplace: A curated B2C revenue stream for medical devices and specialized nutritional products.
-
Prescribable DTx: Moving toward "Digital Health Application" status to unlock insurance reimbursement and clinical prescription.
💰 Investment Opportunity
-
Target: €600k Seed Round
-
Objective: Secure DTx certification, finalize voice-biomarker IP, and scale to 10k+ users.
-
Regulatory Lead: 85% ORCHA score and the CE mark provide a significant head start in the EU regulatory landscape.
Organisation
Similar opportunities
Product
- Software
- Distribution Partner
- Telemedicine solutions
- IT for medical technologies
Damian Delvaux
CEO / COO at EyeVis GmbH
Kiel, Germany
Partnership
Research Collaboration: Advancing Maternal Health Outcomes
- Development
Susa Horvath
Co-Founder, UX Designer at ZenZen Diabetes Support
Berlin, Germany
Service
Selection of Digital Health Solution based on UX methods
- Software
- Consulting
- Data analytics
- Telemedicine and health applications
Michael Engler
Senior Human Factors / Usability Consultant, Geschäftsführer at EMPIANA GmbH
Essen, Germany